Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alnylam, Isis JV Regulus to Tackle MicroRNA

Oct 01 2007

• By Chris Morrison

Related Content

Alnylam Takes Platform Monetization to a Whole New and Non-Exclusive Level

Jul 01 2007

Related Companies

Ionis Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Regulus Therapeutics Inc.

Stanford University

Max Planck Innovation GmbH

Roche Holding AG

Johnson & Johnson

Johnson & Johnson

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window